Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin-Reference-Cited by-同舟云学术

Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin

Published:2018-05-14 Issue:9 Volume:110 Page:967-974
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Rafnar Thorunn¹,Sigurjonsdottir Gudbjorg R²,Stacey Simon N¹,Halldorsson Gisli¹,Sulem Patrick¹,Pardo Luba M³,Helgason Hannes¹⁴,Sigurdsson Stefan T⁵,Gudjonsson Thorkell⁵,Tryggvadottir Laufey⁵⁶,Olafsdottir Gudridur H⁶,Jonasson Jon G⁷⁵,Alexiusdottir Kristin²⁶,Sigurdsson Asgeir¹,Gudmundsson Julius¹,Saemundsdottir Jona¹,Sigurdsson Jon K¹,Johannsdottir Hrefna¹,Uitterlinden Andre⁸,Vermeulen Sita H⁹,Galesloot Tessel E⁹,Allain Dawn C¹⁰¹¹,Lacko Martin¹²,Sigurgeirsson Bardur¹³⁵,Thorisdottir Kristin¹³⁵,Johannsson Oskar T²,Sigurdsson Fridbjorn²,Ragnarsson Gunnar B²,Isaksson Helgi⁷,Hardardottir Hronn¹⁴,Gudbjartsson Tomas¹⁵,Gudbjartsson Daniel F¹¹⁶,Masson Gisli¹,Kiemeney Lambertus A M L⁹,Ewart Toland Amanda¹⁷¹⁸¹⁹,Nijsten Tamar³,Peters Wilbert H M²⁰,Olafsson Jon H¹³⁵,Jonsson Steinn¹⁴,Thorsteinsdottir Unnur¹⁵,Thorleifsson Gudmar¹,Stefansson Kari¹⁵

Affiliation:

1. deCODE Genetics/Amgen, Reykjavik, Iceland

2. Department of Oncology, Landspitali-University Hospital, Reykjavik, Iceland

3. Department of Dermatology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands

4. Faculty of Electrical and Computer Engineering, University of Iceland, Reykjavik, Iceland

5. Faculty of Medicine, University of Iceland, Reykjavik, Iceland

6. Icelandic Cancer Registry, Reykjavik, Iceland

7. Department of Pathology, Landspitali-University Hospital, Reykjavik, Iceland

8. Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, the Netherlands

9. Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands

10. Department of Internal Medicine

11. The Ohio State University, Columbus, OH

12. Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, the Netherlands

13. Department of Dermatology, Landspitali-University Hospital, Reykjavik, Iceland

14. Department of Medicine, Landspitali-University Hospital, Reykjavik, Iceland

15. Department of Surgery, Landspitali-University Hospital, Reykjavik, Iceland

16. School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland

17. Department of Cancer Biology

18. Department of Genetics and Internal Medicine

19. Division of Human Genetics, and The Comprehensive Cancer Center

20. Department of Gastroenterology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands

Funder

deCODE genetics/Amgen

American Cancer Society

National Institutes of Health

National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/110/9/967/25722247/djy002.pdf

Reference38 articles.

1. Hereditary ovarian and breast cancer: What have we learned?;Lynch;Ann Oncol.,2013

2. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer;Wang;Nat Genet.,2014

3. A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer;Delahaye-Sourdeix;J Natl Cancer Inst.,2015

4. Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma;Akbari;Oncogene.,2008

5. Large-scale genotyping identifies 41 new loci associated with breast cancer risk;Michailidou;Nat Genet.,2013

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tackling Non–Small Cell Lung Cancer in Young Adults: From Risk Factors and Genetic Susceptibility to Lung Cancer Profile and Outcomes;American Society of Clinical Oncology Educational Book;2024-06

2. Germline Pathogenic Variants in Patients With Pancreatic and Periampullary Cancers;JCO Precision Oncology;2024-05

3. Personalized treatment with PARP inhibitors in advanced urothelial carcinoma: a case report and literature review;Therapeutic Advances in Medical Oncology;2024-01

4. Clinical response of pancreatic cancer bearing a germline BRCA2 p.I3169M fs*48 variant for platinum-based drug and PARP inhibitor;Japanese Journal of Clinical Oncology;2023-11-11

5. Actionable Genotypes and Their Association with Life Span in Iceland;New England Journal of Medicine;2023-11-09